Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|April 29, 2021
Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indicationsKornelius Fuchs, Silke Rummler, Wolfgang Ries, et al.
Scientific Reports|January 18, 2017
Differential Effects of Vitamins A and D on the Transcriptional Landscape of Human Monocytes during InfectionTilman E Klassert, Julia Bräuer, Martin Hölzer, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|November 20, 2018
Fast and Quantitative Evaluation of Human Leukocyte Interaction with Aspergillus fumigatus Conidia by Flow CytometrySusann Hartung, Christopher Rauh, Thi Ngoc Mai Hoang, et al.
Scientific Reports|January 31, 2017
Modulation of actin dynamics as potential macrophage subtype-targeting anti-tumour strategyCarlo Pergola, Katrin Schubert, Simona Pace, et al.
Scientific Reports|August 26, 2017
Pharmacological profile and efficiency in vivo of diflapolin, the first dual inhibitor of 5-lipoxygenase-activating protein and soluble epoxide hydrolaseUlrike Garscha, Erik Romp, Simona Pace, et al.
Biochemical Pharmacology|September 5, 2016
BRP-187: A potent inhibitor of leukotriene biosynthesis that acts through impeding the dynamic 5-lipoxygenase/5-lipoxygenase-activating protein (FLAP) complex assemblyUlrike Garscha, Susanna Voelker, Simona Pace, et al.
The Journal of Clinical Investigation|July 25, 2017
Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in malesSimona Pace, Carlo Pergola, Friederike Dehm, et al.
Acta Pharmaceutica Sinica. B|July 5, 2021
From Vietnamese plants to a biflavonoid that relieves inflammation by triggering the lipid mediator class switch to resolutionTran Thi Van Anh, Alilou Mostafa, Zhigang Rao, et al.
Biochemical Pharmacology|May 10, 2016
The 5-lipoxygenase inhibitor RF-22c potently suppresses leukotriene biosynthesis in cellulo and blocks bronchoconstriction and inflammation in vivoAnja M Schaible, Rosanna Filosa, Verena Krauth, et al.
Nature Communications|September 22, 2018
Endogenous metabolites of vitamin E limit inflammation by targeting 5-lipoxygenaseHelmut Pein, Alexia Ville, Simona Pace, et al.
Pageof 4